Subtype
Malignant Reproductive System Neoplasm
CI-CAN-00001172Explore in graph →
2,804 active trials38 approved drugs186 evidence items
- NCIt
- C36076
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001172Explore in graph →
Clinical trials
12,158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,473)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03421782 | Fatigue Interventions in Cancer (Exercise Intervention) | completed | Phase 2 | 126 | University of UtahOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT06661902 | Buffered Lidocaine for Reducing Pain in Patients Undergoing Prostate Biopsy, BURN Trial(BURN) | completed | Phase 1 / Phase 2 | 350 | University of WashingtonOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT07413120 | Efficacy and Safety of VasoClip® vs. WeckClip® for Robotic Urologic Surgery | completed | Phase 3 | 40 | Incheon St.Mary's HospitalOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT01543659 | Clinical and Molecular Correlates of Positron Emission Tomography (PET) With 89Zr-DFO-huJ591 in Metastatic Prostate Cancer | completed | Phase 1 / Phase 2 | 77 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 13, 2026 | clinicaltrials |
| NCT02274779 | Salvage Radiotherapy Combined With Hormonotherapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer(OLIGOPELVIS) | completed | Phase 2 | 74 | Institut Cancerologie de l'OuestOTHER | 1 | Feb 13, 2026 | clinicaltrials |
| NCT02313623 | MR-US Image Fusion Targeted Biopsy for Single-cell Prostate Cancer Research | completed | — | 600 | Yale UniversityOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT03995888 | Assessing Radio-hybrid Prostate Specific Membrane Antigen (rhPSMA-7.3) (18F) in Healthy Volunteers and Subjects With Prostate Cancer | completed | Phase 1 | 24 | Blue Earth DiagnosticsINDUSTRY | 1 | Feb 12, 2026 | clinicaltrials |
| NCT04662996 | Search for Predictive Factors of Resistance to Treatment for Metastatic Castration-resistant Prostate Cancer by Studying the Expression of microRNAs(MiR_CPMRC) | completed | N/A | 33 | University Hospital, ToursOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT01517451 | Radiation and Androgen Ablation for Prostate Cancer | completed | Phase 1 / Phase 2 | 45 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT03579394 | Retarded Surgery Following Neoadjuvant Chemotherapy in Advanced Ovarian Cancer(CHRONO) | completed | N/A | 211 | ARCAGY/ GINECO GROUPOTHER | 1 | Feb 10, 2026 | clinicaltrials |
| NCT05870787 | iMproving thE DIagnostics And Treatment Of ceRvical Precancer(MEDIATOR) | completed | — | 929 | University of AarhusOTHER | 1 | Feb 10, 2026 | clinicaltrials |
| NCT07393633 | Assessing Whole-body Metabolism in Gynecologic Cancers in Response to a Single Chemotherapy Cycle and/ or Immunotherapy | completed | — | 43 | University of Tennessee Graduate School of MedicineOTHER | 1 | Feb 10, 2026 | clinicaltrials |
| NCT02195973 | Phase IB Trial of LDE225 and Paclitaxel in Recurrent Ovarian Cancer | completed | Phase 1 | 15 | University of Alabama at BirminghamOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT00893035 | Evaluation of an Apoptotic Test for Predicting Late Toxicities After Radiotherapy in Breast and Prostate Cancer Patients | completed | — | 885 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT02749110 | Participation in Screening for Cervical Cancer: Interest of a Self-sampling Device Provided by the General Practitioner(PaCUDAHL-Gé) | completed | N/A | 308 | University Hospital, LilleOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT03763838 | Acupressure for Fatigue in Ovarian Cancer Survivors | completed | N/A | 171 | University of Michigan Rogel Cancer CenterOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT03981731 | Management of Perioperative Anxiety by the Cardiac Coherence Technique Coupled With a Hypnosis Session(COHEC) | completed | N/A | 53 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT03635567 | Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826) | completed | Phase 3 | 617 | Merck Sharp & Dohme LLCINDUSTRY | 19 | Feb 4, 2026 | clinicaltrials |
| NCT03707574 | Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study | completed | — | 64 | National Cancer Institute (NCI)NIH | 2 | Feb 4, 2026 | clinicaltrials |
| NCT04457089 | Statin Therapy to Reduce Progression in Women With Platinum Sensitive Ovarian Cancer | completed | Early Phase 1 | 18 | Marc GoodmanOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT04484246 | Sarcopenia in Older Patient With Prostate Cancer, Prevalence and Incidence After Androgen Deprivation Therapy(HoSAGE) | completed | — | 112 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT06086665 | The Real World Efficacy and Safety of Niraparib in Korean Women With Primary and Recurrent Epithelial Ovarian Cancer(REFIRM) | completed | — | 850 | Asan Medical CenterOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT06764992 | Exploring Men s Prostate Cancer Genetic Risk Perceptions | completed | — | 100 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT03535831 | PSMA PET Registry (18F-DCFPyL)(PM-PPR) | completed | N/A | 142 | University Health Network, TorontoOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT06662136 | The Effect of Motivational Interviewing on HPV-DNA Testing | completed | N/A | 90 | Muazez küçükkayaOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT07384468 | Ultrasound-Guided Stellate Ganglion Block Plus Propofol for Perimenopausal Insomnia With Anxiety(SGB-PROP-PIA) | completed | N/A | 233 | Xiaochen JiOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT07365969 | Risk of Hysterectomy at Time of Myomectomy | completed | — | 293 | Ain Shams UniversityOTHER | 1 | Jan 30, 2026 | clinicaltrials |
| NCT02407509 | Phase I Trial of VS-6766 Alone and in Combination With Everolimus(RAF/MEK) | completed | Phase 1 | 104 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT05646680 | A Performance Study of (Opportunistic) Salpingectomy(QOS) | completed | N/A | 115 | University Hospital, GhentOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT05701007 | Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland | completed | — | 1,083 | PfizerINDUSTRY | 1 | Jan 29, 2026 | clinicaltrials |
| NCT04089189 | Study of IMP4297 in Patients With BRCA1/2 Mutation Ovarian Cancer(SABRINA) | completed | Phase 2 | 93 | Impact Therapeutics, Inc.INDUSTRY | 1 | Jan 28, 2026 | clinicaltrials |
| NCT02003924 | Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer(PROSPER) | completed | Phase 3 | 1,401 | PfizerINDUSTRY | 32 | Jan 27, 2026 | clinicaltrials |
| NCT03338790 | An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or Enzalutamide in Metastatic Castration-resistant Prostate Cancer(CheckMate 9KD) | completed | Phase 2 | 292 | Bristol-Myers SquibbINDUSTRY | 11 | Jan 27, 2026 | clinicaltrials |
| NCT04640480 | Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors | completed | Phase 1 | 21 | SN BioScienceINDUSTRY | 1 | Jan 27, 2026 | clinicaltrials |
| NCT05011799 | The Peer Genetic Study | completed | N/A | 149 | Thomas Jefferson UniversityOTHER | 1 | Jan 27, 2026 | clinicaltrials |
| NCT03622385 | Exploration of DNA Methylation as a Marker for Early Detection of High Grade Serous Epithelial Ovarian Cancer | completed | — | 10 | Baylor Research InstituteOTHER | 1 | Jan 23, 2026 | clinicaltrials |
| NCT06474065 | Pregnancy Outcomes Following Myomectomy | completed | — | 150 | Centro di Ricerca Clinica SalentinoNETWORK | 1 | Jan 23, 2026 | clinicaltrials |
| NCT04782713 | Smart Prostate Specific Antigen (PSA) Screening Study | completed | N/A | 49 | University of Illinois at ChicagoOTHER | 1 | Jan 22, 2026 | clinicaltrials |
| NCT05360680 | A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers | completed | Phase 1 | 42 | Cue BiopharmaINDUSTRY | 1 | Jan 22, 2026 | clinicaltrials |
| NCT03503344 | Apalutamide With or Without Stereotactic Body Radiation in Treating Castration-Resistant Prostate Cancer(PILLAR) | completed | Phase 2 | 26 | University of California, San FranciscoOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT03578406 | HPV-E6-Specific Anti-PD1 TCR-T Cells in the Treatment of HPV-Positive NHSCC or Cervical Cancer | completed | Phase 1 | 9 | Xinqiao Hospital of ChongqingOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT05470036 | Improving Germline Testing in At-Risk Patients With Prostate Cancer(IMPRINT) | completed | N/A | 50 | University of California, San DiegoOTHER | 1 | Jan 16, 2026 | clinicaltrials |
| NCT03556904 | FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE) | completed | Phase 2 | 14 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jan 15, 2026 | clinicaltrials |
| NCT04763824 | KanSurvive: Testing a Model for Improving Cancer Survivorship Care in Rural Practice(KANSURVIVE) | completed | N/A | 15 | University of Kansas Medical CenterOTHER | 1 | Jan 14, 2026 | clinicaltrials |
| NCT00186368 | Microarray Analysis of Gene Expression in Prostate Tissues | completed | — | 867 | Stanford UniversityOTHER | 1 | Jan 12, 2026 | clinicaltrials |
| NCT07333807 | Efficacy of the Pelvic Clock® Device for Functional Recovery After Robotic-Assisted Radical Prostatectomy | completed | N/A | 60 | Tri-Service General Hospital (TSGH)OTHER | 1 | Jan 12, 2026 | clinicaltrials |
| NCT04870515 | Diet and Physical Activity Intervention for the Prevention of ADT-Induced Metabolic Changes in Patients With Prostate Cancer, TRIPLE-A PILOT Study | completed | N/A | 20 | Fred Hutchinson Cancer CenterOTHER | 1 | Jan 9, 2026 | clinicaltrials |
| NCT05041257 | Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers(PICCOLO) | completed | Phase 2 | 79 | AbbVieINDUSTRY | 7 | Jan 9, 2026 | clinicaltrials |
| NCT05041504 | A Web-based Peer Navigation Program for Men With Prostate Cancer | completed | N/A | 184 | University Health Network, TorontoOTHER | 1 | Jan 9, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Feb 17, 2026source: clinicaltrials